Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use EVKEEZA safely and effectively. See full prescribing information for EVKEEZA. EVKEEZA® (evinacumab-dgnb) injection, for intravenous use Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
EVKEEZA is indicated as an adjunct to diet and exercise and other low-density lipoprotein-cholesterol (LDL-C) lowering therapies to reduce LDL-C in adults and pediatric patients, aged 1 year and older, with homozygous familial hypercholesterolemia (HoFH).
- generic_name
- evinacumab
- product_names
- evinacumab
- ndc
- 61755-013, 61755-010, 61755-013-01, 61755-010-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en